Inhibition survey with phenolic compounds against the δ- and η-class carbonic anhydrases from the marine diatom

Antiprotozoal Agents / chemical synthesis Carbonic Anhydrase Inhibitors / chemical synthesis Carbonic Anhydrases / metabolism Diatoms / enzymology Dose-Response Relationship, Drug Humans Molecular Structure Parasitic Sensitivity Tests Phenols / chemical synthesis Plasmodium falciparum / drug effects Structure-Activity Relationship
Diatom inhibition metalloenzyme protozoan δ-/η-class

Journal

Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203

Informations de publication

Date de publication:
Dec 2020
Historique:
entrez: 21 12 2019
pubmed: 21 12 2019
medline: 15 2 2020
Statut: ppublish

Résumé

The inhibition of δ- and η-class carbonic anhydrases (CAs; EC 4.2.1.1) was poorly investigated so far. Only one δ-CA, TweCA from the diatom

Identifiants

DOI: 10.1080/14756366.2019.1706089 PMID: 31856608 PMC: PMC6968676
pubmed: 31856608
doi: 10.1080/14756366.2019.1706089
pmc: PMC6968676
doi:

Substances chimiques

Antiprotozoal Agents 0
Carbonic Anhydrase Inhibitors 0
Phenols 0
Carbonic Anhydrases EC 4.2.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

377-382

Références

J Enzyme Inhib Med Chem. 2018 Dec;33(1):1453-1459
pubmed: 30221552
Angew Chem Int Ed Engl. 2007;46(40):7697-9
pubmed: 17705204
Southeast Asian J Trop Med Public Health. 2003;34 Suppl 2:32-43
pubmed: 19230569
Nature. 2008 Mar 6;452(7183):56-61
pubmed: 18322527
J Enzyme Inhib Med Chem. 2018 Dec;33(1):139-146
pubmed: 29192555
Bioorg Med Chem Lett. 2014 Sep 15;24(18):4389-4396
pubmed: 25168745
J Med Chem. 2018 Jun 28;61(12):5380-5394
pubmed: 29851481
Bioorg Med Chem Lett. 2016 Sep 1;26(17):4184-90
pubmed: 27485387
J Med Chem. 2012 Jun 14;55(11):5529-35
pubmed: 22578027
Chemistry. 2018 Jun 4;24(31):7840-7844
pubmed: 29603439
Chem Rev. 2012 Aug 8;112(8):4421-68
pubmed: 22607219
J Enzyme Inhib Med Chem. 2018 Dec;33(1):485-495
pubmed: 29390912
Nature. 2005 May 5;435(7038):42
pubmed: 15875011
Proc Natl Acad Sci U S A. 2016 Aug 30;113(35):9828-33
pubmed: 27531955
Biochem J. 2016 Jul 15;473(14):2023-32
pubmed: 27407171
J Inorg Biochem. 2012 Jun;111:117-29
pubmed: 22192857
J Med Chem. 2018 Dec 13;61(23):10860-10874
pubmed: 30433782
ChemMedChem. 2018 Apr 23;13(8):816-823
pubmed: 29575699
Physiol Plant. 2008 May;133(1):78-91
pubmed: 18405334
Bioorg Med Chem Lett. 2011 Jul 15;21(14):4259-62
pubmed: 21669522
Expert Opin Drug Discov. 2019 Nov;14(11):1175-1197
pubmed: 31436118
J Enzyme Inhib Med Chem. 2017 Dec;32(1):51-59
pubmed: 27784170
J Med Chem. 2000 Nov 16;43(23):4542-51
pubmed: 11087579
Biochemistry. 2000 Oct 10;39(40):12128-30
pubmed: 11015190
Acta Crystallogr D Biol Crystallogr. 2014 Oct;70(Pt 10):2607-18
pubmed: 25286845
J Enzyme Inhib Med Chem. 2014 Dec;29(6):906-11
pubmed: 24456295
Biochemistry. 2000 Aug 8;39(31):9222-31
pubmed: 10924115
Nat Rev Drug Discov. 2008 Feb;7(2):168-81
pubmed: 18167490
Med Hypotheses. 1998 Jan;50(1):19-23
pubmed: 9488177
J Enzyme Inhib Med Chem. 2018 Dec;33(1):629-638
pubmed: 29536779
Bioorg Med Chem. 2009 Apr 15;17(8):3207-11
pubmed: 19231207
J Med Chem. 1999 Sep 9;42(18):3690-700
pubmed: 10479300
J Enzyme Inhib Med Chem. 2016;31(sup4):54-59
pubmed: 27615265
Expert Opin Ther Targets. 2015;19(12):1689-704
pubmed: 26235676
Metabolites. 2018 Mar 21;8(2):
pubmed: 29561812
J Biol Chem. 1971 Apr 25;246(8):2561-73
pubmed: 4994926
ISME J. 2019 Aug;13(8):2094-2106
pubmed: 31024153
Bioorg Med Chem Lett. 2014 Jan 1;24(1):275-9
pubmed: 24314394
Org Biomol Chem. 2016 Sep 21;14(35):8322-30
pubmed: 27530867
J Enzyme Inhib Med Chem. 2018 Dec;33(1):999-1005
pubmed: 29806484
J Enzyme Inhib Med Chem. 2018 Dec;33(1):707-713
pubmed: 29577755
Bioorg Med Chem. 2016 Sep 15;24(18):4410-4414
pubmed: 27480028
J Enzyme Inhib Med Chem. 2014 Aug;29(4):495-9
pubmed: 23808805
J Med Chem. 2011 Mar 24;54(6):1682-92
pubmed: 21332115
Bioorg Chem. 2019 Dec;93:103336
pubmed: 31604186
Bioorg Med Chem Lett. 2015 Apr 1;25(7):1385-9
pubmed: 25765908
Bioorg Med Chem. 2017 May 1;25(9):2577-2582
pubmed: 28343756
J Enzyme Inhib Med Chem. 2016;31(3):345-60
pubmed: 26619898
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1565-1574
pubmed: 30274535
Bioorg Chem. 2018 Apr;77:293-299
pubmed: 29421705
Plant Physiol. 2000 May;123(1):345-52
pubmed: 10806251

Auteurs

Siham A Alissa (SA)

Chemistry Department, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

Hanan A Alghulikah (HA)

Chemistry Department, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

Zeid A ALOthman (ZA)

Chemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia.

Sameh M Osman (SM)

Chemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia.

Sonia Del Prete (S)

Istituto di Bioscienze e Biorisorse, CNR, Napoli, Italy.

Clemente Capasso (C)

Istituto di Bioscienze e Biorisorse, CNR, Napoli, Italy.
ORCID: 0000-0003-3314-2411

Alessio Nocentini (A)

NEUROFARBA Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Sesto Fiorentino, Firenze, Italy.

Claudiu T Supuran (CT)

NEUROFARBA Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Sesto Fiorentino, Firenze, Italy.
ORCID: 0000-0003-4262-0323

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antiparasitaires › Antiprotozoaires › Inhibition survey with phenolic compounds...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Mécanismes moléculaires de l'action pharmacologique › Antienzymes › Inhibiteurs de l'anhydrase carbonique › Inhibition survey with phenolic compounds...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Lyases › Carbon-oxygen lyases › Hydro-lyases › Carbonic anhydrases › Inhibition survey with phenolic compounds...
questionsmedicales.fr › Eucaryotes › Straménopiles › Diatomées › Inhibition survey with phenolic compounds...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes toxicologiques › Relation dose-effet des médicaments › Inhibition survey with phenolic compounds...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Inhibition survey with phenolic compounds...
questionsmedicales.fr › Phénomènes chimiques › Structure moléculaire › Inhibition survey with phenolic compounds...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité parasitaire › Inhibition survey with phenolic compounds...
questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Hydrocarbures cycliques › Hydrocarbures aromatiques › Dérivés du benzène › Phénols › Inhibition survey with phenolic compounds...
questionsmedicales.fr › Eucaryotes › Alveolata › Apicomplexa › Haemosporida › Plasmodium › Plasmodium falciparum › Inhibition survey with phenolic compounds...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Relation structure-activité › Inhibition survey with phenolic compounds...